-
Immuneering (NASDAQ:IMRX) Given "Buy" Rating at Chardan Capital
Source: Buzz FX / 08 Jan 2025 07:26:15 America/Chicago
Immuneering (NASDAQ:IMRX) Given "Buy" Rating at Chardan Capital Written by MarketBeat January 8, 2025 Share Link copied to clipboard. Immuneering ( NASDAQ:IMRX - Get Free Report ) 's stock had its "buy" rating reaffirmed by research analyst
Read more...